BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
NEUROG3
,
Coagulation
,
Ischemia
,
Lymphocyte
,
Autoimmunity
,
Vitamin E
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PD 1
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
CD8+ CD3+ T cells from peripheral blood - PD-1-high, PD-1-low and naive
Explore Curated Studies Results
Literature
Most Relevant Literature
PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism.
Increased PD-1 Level in Severe Cervical Injury Is Associated With the Rare Programmed Cell Death 1 (…
New Insights into the Role of PD-1 and Its Ligands in Allergic Disease.
PD-1 cooperates with AIRE-mediated tolerance to prevent lethal autoimmune disease.
PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Duration of Anti-PD-1 Therapy in Metastatic Melanoma
Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyng…
SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Contro on PD-1/PDL-1 Tx
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ